Julia Blanchette, RN, PhD
- Assistant Professor, CWRU School of Medicine
- Nurse Scientist and Diabetes Care and Education Specialist, UH Cleveland Medical Center
- Clinical Assistant Professor, Medicine CWRU School of Medicine
- Specialty: Diabetes Education
-
Location:University Hospitals
5885 Landerbrook Dr
Mayfield Heights, OH 44124
- Call: 216-286-8988
Biography: Julia Blanchette, RN, PhD
Certifications & Memberships
- BC-ADM Board Certified, Advanced Diabetes Management - Association of Diabetes Care and Education Specialists
- Certified Diabetes Care and Education Specialist (CDCES) - Certification Board for Diabetes Care and Education
- Registered Nurse (RN) - Ohio Board of Nursing
About
Julia Blanchette, PhD, RN, BC-ADM, CDCES, is a Nurse Scientist Lead, Diabetes Care and Education Specialist and Program Director of Diabetes Research at University Hospitals Cleveland Medical Center and an Assistant Professor of Medicine at Case Western Reserve University School of Medicine. She received her BSN in Nursing Science from the Frances Payne Bolton School of Nursing at Case Western Reserve University in 2014 and her PhD from Case Western Reserve University School of Graduate Studies in 2019. She was the inaugural Association of Diabetes Care and Education Specialists (ADCES) and Certification Board for Diabetes Care and Education (CBDCE) Post-Doctoral Fellow. She completed her post-doctoral fellowship at the University of Utah College of Nursing in Integrated Diabetes Management in 2021.
Dr. Blanchette examines the impacts of financial, psychological and health literacy barriers on diabetes self-management behaviors and outcomes during emerging adulthood and throughout the lifespan. She is dedicated to intervention development through community-engaged research. She employs qualitative, mixed-methods and quantitative analyses with interdisciplinary clinicians and scientists. She is a diabetes technology expert and seeks to reduce healthcare disparities and increase technology utilization. She also explores barriers and solutions to facilitate the transition from pediatric to adult diabetes care. Dr. Blanchette is currently the principal investigator for the Type 1 Diabetes Financial Toolkit for Emerging Adults (iHERO study) (2023-2026), funded by The Leona M. and Harry B. Helmsley Charitable Trust and a Co-Investigator on A Cognitive Behavioral Sleep Self-Management Intervention for Young Adults with Type 1 Diabetes (R01DK136604) funded by the NIDDK.
Research & Publications
Research Links
PubMed
View Research
Industry Relationships
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Julia Blanchette did not disclose any Outside Relationships with Industry.